TEchCrunch : Hyperloop Transportation Technologies signs first cross-state deal

Hyperloop Transportation Technologies signs first cross-state deal in the U.S.

One of the two major dedicated companies pursuing the creation of functional Hyperloops (high-speed tunnel transportation that can zoom pods around in low pressure) has signed its first agreements that could lead to an interstate Hyperloop system.
The deal with Hyperloop Transportation Technologies (HTT) includes agreements with both the North Ohio Areawide Coordinating Agency (NOACA) and the Illinois’ Department of Transportation (IDOT) to start work on a feasibility study, the first step of determining whether it’s even possible to build a route before beginning work in earnest. The study will focus on determining the viability of a number of different corridors, all the with the goal of connecting Cleveland and Chicago.
HTT notes that Ohio’s legislature passed a resolution supporting the initiative in January of this year, and that it’s also worked with congressional representatives from multiple states to jointly send a formal letter to the Trump administration asking for federal funding support for building out a Hyperloop network.

This now stand as the “first real public-private partnership to bring Hyperloop travel to the US,” HTT CEO Dirk Ahlborn said in a statement provided to TechCrunch.
HTT has agreements in place already with a number of other public partners worldwide, including in India and Europe. Most of the work is still in the planning phase, however, so watch this space for news of breaking ground and commencing construction, which is hopefully the next step for at least some of these initiatives.

TEchjCrunch : As Stripe backs away from crypto payments, Coinbase offers a new s

As Stripe backs away from crypto payments, Coinbase offers a new solution for e-commerce

Popular payment enabler Stripe announced plans to end support for bitcoin last month, but crypto exchange Coinbase is stepping into the gap after it released a new option for online merchants.
Coinbase — which is best known for its service that converts fiat into bitcoin, Ethereum, Litecoin or Bitcoin Cash — is valued at $1.6 billion after raising $100 million last year. The company reportedly booked $1 billion in revenue last year, according to Recode, and it claims to have served over 10 million users. Now, it is looking to give retailers a more flexible option for collecting payment in crypto.
Coinbase Commerce — its new service launched this week — lets merchants add crypto payment options direct to their existing payment flow or added as a separate option. Unlike past retailer solutions from Coinbase, it is hosted independently of the exchange’s services so a merchant can receive crypto to its own wallet. It is also supported worldwide, so not just in the U.S..
The company has its first integration with Shopify, the e-commerce hosting site that claims over 500,000 merchants worldwide.
Offering a solution is one thing, but some merchants have been burned. Steam, for example, stopped support on account of the rising cost of transactions. While there are new solutions coming to the fore to reduce those fees and quicken transactions — Coinbase itself is among the trialists — and the cost has dropped noticeably of late, merchants may still be reluctant on account of price volatility.

Then there’s the question of whether crypto holders will spend their digital currency rather than keep hold of it in the hope that it’ll be worth more.
Bitcoin, Ethereum and others went on a tear last year, with huge valuation gains, but a bloody dip over the past month has seen those prices drop — with the value of bitcoin falling from an all-time high of nearly $20,000 to around $9,000 right now.
Nonetheless, Coinbase has a solution that will allow those who want in, the chance to buy and sell using crypto.

FT : Russian sovereign fund eyes investor consortium for Saudi Aramco IPO

Russian sovereign fund eyes investor consortium for Saudi Aramco IPO

The Russian Direct Investment Fund, a $10bn sovereign fund, said on Thursday it could set up a “significant consortium” of investors for the planned initial public offering of Saudi Arabia’s state energy giant Saudi Aramco.

Kirill Dmitriev, the head of the fund, said he expects widespread interest from Russian financial groups for the public offering tipped to be the world’s biggest ever.

“We see significant interest from Russian banks, from Russian investment banks and a number of other Russian investors, so we believe that we will be able to create a fairly significant consortium for these investments,” he told reporters at a conference in Sochi.

Mr Dmitriev has previously said that Russian pension funds were considering participating in the Saudi Aramco IPO, which the kingdom hopes will take place later this year. Crown Prince Mohammed bin Salman, who is driving plans as part of broader economic reforms, believes Saudi Aramco could be valued at $2tn and the IPO could raise $100bn through a 5 per cent sale.

Mr Dmitriev added that RDIF has been working with Chinese entities to facilitate their participation in the share sale, which would likely include several big cornerstone investors.

“We are helping our partners, including Russian and Chinese, to invest in this company,” Mr Dmitriev added, in remarks reported by Interfax. Although he conceded that “the share of the [RDIF] itself will be absolutely minimal.”

Saudi Arabia is weighing different options for the privatisation of Saudi Aramco which could include an international listing — in London, New York or Hong Kong — alongside one on the domestic Tadawul market. It is also considering a private sale.

While the kingdom is targeting a late 2018 listing, advisers and Saudi Aramco executives think 2019 is more likely.

Russia and Saudi Arabia — big resource-rich nations that pump a fifth of the world’s oil — have put aside their longstanding rivalry to forge an international agreement on curbing oil production to bolster the market after a three year downturn in prices.

Their partnership, politically and economically, has since thrived with both nations seeking investments in the wider energy sector and beyond as the two countries become closer despite their differences in global conflicts such as Syria.

For Russia the Saudi relationship, as well as a stronger link with China, is helping to offset souring relations with the west and the impact of financial sanctions that have curbed funding from US and European banks.

Russia’s largest non-state natural gas producer Novatek and Saudi Aramco are preparing to announce an agreement that could involve the Saudi state giant’s involvement in a planned new Arctic gas project. This follows comments by Russia’s energy minister Alexander Novak this week that a deal was close.

The agreement is pending final approvals and could include liquefied natural gas supply contracts such as a possible investment in Novatek’s Arctic LNG 2 project, a person with knowledge of the talks said.

French energy major Total and Chinese energy group CNPC are shareholders in Novatek’s $27bn Yamal LNG plant which began shipments this winter. The Russian company has long said that it is in discussions with potential Saudi partners in future gas projects.

Saudi Aramco has said it is keen to make investments in gas abroad, although the company has divulged little information about any Russian deals. A Novatek spokesman declined to comment.

Mr Novak, who headed a Russian delegation in Saudi Arabia this week, also said that the state-owned nuclear company Rosatom had applied for a tender to construct two power plants in Saudi Arabia.

(SG) Fundamentals are nearly always strong when the market start

Fundamentals are nearly always strong when the market starts to sell-off

* Global equity markets slumped last week, losing 5.6%, the worst week since January 2016.
The index has now dropped 8.8% from its recent high, having at one point been down over
10%, and volatility has snapped higher. To all extent and purpose the selling appears top-down
led, with all indices down by a similar amount, particularly when viewed in US dollar terms.
However there are some exceptions, most notably Japan, which fell 8.1% last week in the face
of a strengthening Yen. China was also weak with the CS300 off over 10% last week. And MSCI
Germany has seen the biggest peak to trough losses. So clearly currency, or more specifically
US dollar weakness, is going to be a contentious issue in 2018.

* When markets correct, the standard retort is that in the long-term it pays to stay invested and
that the fundamentals remain strong and supportive. So we had a look at prior corrections in the
S&P 500 to see how fundamentals looked at the point when the market turned. Using data since
1985 (as we wanted to include consensus growth expectations) at the point when the S&P 500
dropped 10% or more, on average the US ISM index was at 51.6 (indicating economic
expansion), trailing EPS growth was on average running at 7% and forward growth expectations
were at 11%. The point being that at the top, economic fundamentals always look strong and
this is why interest rates are going up. It is interest rates, not growth, that is the concern.

* How long it takes you to recover from your index price loss varies widely; the mild corrections
in 1998 and 1999 took under 90 trading days to get back to the initial index level. This compares
to the 2000 and 2007 corrections which took over 1800 and 1400 days respectively to recover
the prior price level. In such long draw down periods, the compounding dividend takes on added
performance, as in total return terms although you made no money in price terms from 2000 to
2007, at least you made 12.5% via the dividend. Another good reason to avoid dividend cuts.

* So far we have seen very little in the way of fundamental stock price discrimination. During
the worst day of selling, we saw some of the lowest ever cross sectional stock dispersion for a
down market of such magnitude. In brief it looks like investors were selling markets, not stocks,
a fact also reflected in the initial outperformance of small-caps versus large-caps.

* So far we have seen very little in the way of fundamental stock price discrimination. During
the worst day of selling, we saw some of the lowest ever cross sectional stock dispersion for a
down market of such magnitude. In brief it looks like investors were selling markets, not stocks,
a fact also reflected in the initial outperformance of small-caps versus large-caps.

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
:

  • FORD -12.1%, NTAP -9.9%, THS -9.3%, SPWR -8.8%, NEPT -5.1%, HL -5%, CAI -4.8%, KGC -4%, XEC -4%, QTWO -4%, EQIX -3.9%, MAR -3.3%, PDS -3.2%, HCC -3%, LIVE -2.3%, (also discloses conclusion that several previously issued financial statements should no longer be relied upon), ALSN -2.2%, SHOP -1.9%, SON -1.8%, PPC -1.5%, AEM -1.2%, OMF -1.1%

Other news:

  • INPX -29.2% (launched public offering)
  • CDMO -27.7% (prices 9 mln shares of common stock at $2.25 per share)
  • FOLD -3.7% (announces $250 mln public offering of common stock)
  • DSKE -2.9% (prices 7.5 mln shares of common stock at $10.60 per share)
  • ATKR -2.1% (commences 6 mln common stock offering by selling stockholder Clayton, Dubilier & Rice)
  • CMP -1.1% (lower on light volume after being downgraded to Underperform from Neutral at Credit Suisse )
  • RUN -0.9% (following SPWR results)

Analyst comments:

  • CMP -1.1% (downgraded to Underperform from Neutral at Credit Suisse)
  • PDCO -2.8% (downgraded to Underweight from Neutral at JP Morgan)
  • CX -3.3% (downgraded to Sell from Buy at UBS)
  • ATRA -6.2% (downgraded to Sell from Neutral at Citigroup)

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
:
  • TRIP +17.2%, SEDG +15.6%, PKD +15.5%, SDPI +14.2%, YNDX +8.4%, DRD +8.1%, CTL+7.7%, CSCO +7.3%, ACOR +5.5%, VNDA +5%, ARRS +4.2%, CC +4.2%, A +4%, LPI +4%,USFD +4%, WM +3.7%, MMLP +3.5%, MRO +3.5%, AVP +3.5%, KIM +3.4%, GG +3%, AEG+2.8%, CCE +2.7%, HII +2.6%, GEL +2.5%, CVE +2.4%, CF +2.2%, ECA +2.2%, ZTS +2.1%,GROW +2%, INCY +2%, NLY +1.8%, SB +1.4%, CYBR +1.4%, GPN +1.3%
M&A news:
  • SHLM +8.7% (to be acquired by LyondellBasell (LYB) for $2.25 bln, or $42/share)
  • NOK +1.6% (initiates strategic review of its Digital Health business)
Select names showing strength following following 13F filings:
  • TEVA +7.6% (Berkshire Hathaway and Jana disclose new position)
  • OSTK +5.7% (Soros Fund Management discloses new stake)
  • SWN +2.7% (new Third Point /Dan Loeb stake)
  • CVG +2.3% (Elliott Management discloses new stake)
  • JCP +1.6% (Greenlight Capital - David Einhorn - disclosed new stake)
  • NFLX +0.9% (Third Point disclosed new stake)
  • BHF +0.9% (David Einhorn's Greenlight Capital disclosed new stake)
Other news:
  • ATRS +20.2% (FDA approval of partner's product utilizing QuickShot Auto Injector),AMAG +19.8% (FDA approved Makena subcutaneous auto-injector to reduce risk of preterm birth; to file NDA for Bremelanotide later this quarter), COOL +17.6% (was initiated with Overweight rating and $70 tgt at Cantor Fitzgerald after the close),OMER +14.7% (announces new results from the company's ongoing Phase 2 study of OMS721 evaluating patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy), ARWR +9.7% (receives regulatory clearance to begin Phase 1/2 study of ARO=HBV for treatment of Hepatitis B), HIIQ +7.6% (executed a consent order granting a Certificate of Authority to conduct business as a third-party insurance administrator in the State of Florida to Health Plan Intermediaries Holdings),SBCF +5% (will replace Deltic Timber (DEL) in the S&P SmallCap 600), AXON +4.9% (initiated a corporate realignment to focus its efforts and resources on its ongoing and future programs that included a reduction in its workforce), BLDP +3.2% (wins $4.2 mln program to develop next-gen air-cooled fuel cell stack for forklift trucks ), NBIX +3.1% (Neurocrine Biosci announced that the FDA has provided guidance on the regulatory path forward to support the New Drug Application NDA for Opicapone), TRVG +2.2% (following TRIP results), BEN +2% (announces $3 special dividend), RMBS +1.5% (Rambus signs license agreement with Gemalto to protect against side-channel attacks ), SHPG +1.5% (FDA accepted the CINRYZE sBLA to expand the currently approved indication to include children aged 6 years and older with hereditary angioedema),TRP +1.5% (will move forward with a $2.4 billion expansion of its NGTL System), CRBP+1.4% (announces data from a human clinical model shows that lenabasum (formerly known as anabasum) is an activator of resolution of innate immune responses and is the first experimental therapeutic shown to activate this pathway in humans), BAC+1.1% (reports out that Amazon/ BofA partnering for lending program; also new Senator Investment Group and Owl Creek disclosed news stakes, Appaloosa/David Tepper increased stake), PCLN +1.1% (following TRIP results; also Meritage disclosed new stake), EXPE +1% (following TRIP results), .
Analyst comments:
  • ADVM +4.6% (resumed with a Overweight at Piper Jaffray)
  • CRM +2.2% (upgraded to Buy from Hold at Jefferies)
  • BIDU +2% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
  • DNOW +2% (upgraded to Buy from Neutral at Seaport Global Securities)
  • CRTO +1.8% (upgraded to Overweight from Sector Weight at KeyBanc Capital Mkts)
  • BMY +1.5% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
  • KLAC +1.5% (upgraded to Buy from Neutral at Citigroup)
  • OHI +1.4% (upgraded to Outperform from Market Perform at Wells Fargo)
  • BG +1.1% (upgraded to Overweight from Equal-Weight at Stephens)
  • MRNS +0.8% (initiated with a Buy at H.C. Wainwright; tgt $33 (closed at 6.08 on Wed))
  • DK +0.7% (upgraded to Neutral from Underperform at BofA/Merrill)
  • PBYI +0.7% (added to US Focus List at Citigroup)

>>> Linde/Praxair: Helium divest packages could vary by geography

Linde/Praxair: Helium divest packages could vary by geography

  • US refinery sale seen quick fix
  • European supply contracts sales may be harder to execute
  • Value of contracts likely higher than refinery disposal

The nature of helium divestitures in Linde [ETR:LIN] and Praxair’s [NYSE:PX] proposed merger could vary by geography, said a third party source, a source familiar with the matter and two competition lawyers.
In the US, a potential divestiture of one of the parties’ helium refineries is an obvious solution given the gas supply chain, the sources and two lawyers said. In Europe, however, the parties’ lack of refineries could make helium supply contracts a more logical remedy, the sources and the first lawyer said.
News reports indicated the parties could expect to divest more assets than expected after Linde announced last week that the deal’s regulatory clearance could “be subject to requirements more onerous than previously assumed.” Divestitures could now hit EUR 800m in EBITDA, it was reported. This is still below the parties' commitments to divest assets worth up to EUR 3.7bn in revenue and EUR 1.1bn in EBITDA to close the transaction.
Brazilian, European and US antitrust authorities are reviewing the merger along with agencies in several other jurisdictions.

US helium divestitures
The merging parties have a relatively simple path to resolving helium business overlap should regulators focus on refining versus extraction in the US, the third party source said. A divestiture of one of the parties’ US refineries could substantially remedy potential concerns given the current four-refinery market dynamic, this source and the first lawyer said.
The helium refinery market in the US is concentrated, with Air Products [NYSE:APD], Praxair, Linde, and KeyesHelium owning major refineries that convert crude helium gas into byproducts. Three of the refineries do far more business than the fourth, the third party source cautioned.
Gas is extracted on land operated by the US’ Bureau of Land Management (BLM), and sold to these refineries concentrated near the BLM’s Hugoton-Panhandle complex in Texas.
The refineries account for a significant proportion of refined helium in a market the European Commission (EC) has previously defined as worldwide in wholesale and national in retail. As of 2008, plants connected to the US Bureau of Land Management’s crude helium extraction system accountedfor 3.65 billion cubic feet (BcF) of refined helium per year relative to the total US production of 5.33 BcF per year. For the same period, non-US production comprising assets in Algeria, Poland, Qatar and Russia amounted to 1.86 BcF per year.
The sale of either Linde’s or Praxair’s US helium refinery could be financially feasible for the parties, the third party source said. A divestiture value could be reasonable relative to the size of Linde and Praxair’s divestiture cap, this source said, but declined to specify further.
The Federal Trade Commission (FTC) might also accept a larger pool of bidders for the helium refinery than for some other divestiture assets, said two sources briefed on the matter. A non-industrial gases strategic could be a credible bidder for the helium business providing that the company has the technological know-how and hands-on experience in a related field, such as liquefied natural gas (LNG), they said.
The universe of such buyers for the helium business could include General Electric [NYSE:GE], the sources briefed said. Both sources briefed cited GE’s large-scale LNG technologies expertise as well as its cryogenic plant design capabilities for LNG and carbon dioxide applications.
However, the source familiar said that the most logical bidder pool for a US helium refinery would be current industrial gas suppliers.
Helium contract sales
In Europe, the parties’ principal helium market overlap is in supply contracts, the source familiar said. Linde and Praxair hold the rights to helium supplies rather than ownership of refineries in Europe.
In Linde/BOC 2006, the EC noted helium wholesalers active in Europe sourced the gas from deposits in Poland, Russia, Algeria, Qatar, and the US. The EC found that existing long-term contract supplier BOC’s combination with ‘maverick’ new entrant Linde would reduce the incentive for price competition and “raise the risk of tacit collusion” among the resulting four industry participants.
The parties have helium supply contracts with customers that could be difficult to transfer, the third party source said. Potential buyers might not want the political risk attached to exposure to some of the producing countries’ governments, while integrated contract schemes themselves can be very difficult to disentangle in time for a sale, he said.
In Linde/BOC, for instance, two possible contract remedies for the helium market were tabled. The first proposal was dropped given negative feedback about whether the proposed divestiture would be sold in time. But, the EC ultimately accepted an alternative remedy package containing two specific Linde and three specific BOC helium supply contracts with a larger combined volume than the initial remedy proposal. Assets and customer contracts were added to the package as well, because a market test indicated they were also needed for the remedy's viability.
Linde/BOC was cleared in Phase I of the EC’s merger review.
Helium contracts are often sold back to back as they roll off, the source familiar said. That makes the kind of contract sale that could be required by regulators a fairly standard industry transaction, he and the first competition lawyer agreed.
It is unclear what the value of Linde and Praxair’s helium supply contracts is, but a sale of several contracts is likely to be far larger than the value of a refinery transaction, the third party source said.
Onsite tonnage, a bulk gas delivery method, was previously reported to be a potential sticking point with regulators given the parties’ overlapping footprints. Helium provision, however, has been treated as a distinct market by the European Commission in previous industrial gas reviews.
Linde and Praxair declined to comment.